Vivian Lee

Over 30 years experience in life science advisory, investment and portfolio management. Has advised hundreds of companies, investment firms, universities and government agencies worldwide, frequent speaker at biotechnology investment conferences in US, Europe and Asia, served as a reviewer to the US Congressional Office of Technology Assessment in its first report on commercial biotechnology in 1983. Served as Venture Partner of Global Biomedical Partners, managing $400 million International Biomedicine Fund. Former member of Board of Directors of Innodia Inc and observer on board of Syntonix Pharmaceuticals. Previously served as analyst in the Office of New Ventures of WR Grace & Co. A.B., Biochemistry from Harvard University, conducted research in tumor immunology at Dana Farber Cancer Center and Yale University School of Medicine.